Related Experiment Video

Updated: Jun 12, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

PAK1 as a therapeutic target

Julia V Kichina1, Anna Goc, Belal Al-Husein

  • 1Roswell Park Cancer Institute, Department of Cell Stress Biology, Elm and Carlton Streets, Buffalo, NY 14263, USA.

Expert Opinion on Therapeutic Targets
|May 29, 2010
PubMed
Abstract

Insights

P21-activated kinase 1 (PAK1) is a key regulator in cell processes and a promising therapeutic target for cancer and allergic disorders. Further research is needed to develop effective PAK1 inhibitors and clarify its role in other diseases.

Area of Science:

  • Cellular signaling and molecular biology
  • Signal transduction pathways
  • Mammalian cell biology

Background:

  • P21-activated kinases (PAKs) are crucial in mammalian cell signaling.
  • PAK1 specifically influences cell motility, survival, proliferation, cytoskeleton organization, and gene expression.
  • Dysregulation of PAK1 is implicated in cancer, mental retardation, and allergic conditions.

Purpose of the Study:

  • To review the regulatory mechanisms of PAK1 activity.
  • To examine PAK1's role in physiological and pathophysiological processes.
  • To evaluate PAK1 as a therapeutic target and discuss future research directions.

Main Methods:

  • Review of existing literature on PAK1.
  • Analysis of mechanisms controlling PAK1 activity.
  • Discussion of therapeutic tools and strategies for PAK1 modulation.

Main Results:

  • PAK1 activity is controlled by various mechanisms.
  • PAK1 plays a significant role in numerous cellular functions.
  • Current tools for PAK1 regulation have both benefits and drawbacks.

Conclusions:

  • PAK1 presents a promising therapeutic target for cancer and allergic diseases.
  • PAK1's therapeutic utility in vascular, neurological, and infectious diseases requires further investigation.
  • Advancements depend on developing specific inhibitors, understanding isoform-specific roles, and overcoming resistance mechanisms.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...